HOME >> BIOLOGY >> NEWS
Walnut consumption may reduce heart disease risk by beneficially redistributing cholesterol

Although consumption of as little as 5 ounces of nuts per week has been shown to reduce cardiovascular (CVD) risk by 30-50%, most studies have not differentiated the effects of specific types of nuts. Walnuts are unique as a rich source of n-3 and n-6 polyunsaturated fatty acids (PUFAs). In a study of older subjects, Almario et al. demonstrated that walnuts added to the diet have a dual effect of lowering both total cholesterol and low-density lipoprotein (LDL) cholesterol.

The 5 men and 13 postmenopausal women in the study averaged 60 years of age and had high serum cholesterol levels. Over a 5-1/2 month period, they consumed four diets in sequence: their habitual diet (HD), HD + walnuts , a low-fat diet (LFD), and a LFD + walnuts. Walnuts were provided at 48 grams per 1850 dietary calories per day. Compared with both the HD and LFD, the LFD + walnuts significantly reduced total cholesterol and LDL-cholesterol concentrations. Compared to the diets without walnuts, the proportion of small particle LDL decreased by 27% with the HD + walnuts and 7% with the LFD + walnuts. Small particle LDL is considered to be a promoter of CVD. None of the subjects gained weight during the walnut diets, even though their energy intakes increased.

The authors conclude that the metabolic effect of walnuts is favorable, and that walnuts affect lipid metabolism differently than other food sources of n-3 and n-6 fatty acids, such as fish oil and soybean products.


'"/>

Contact: Sharon Lovejoy
sllovejoy@ucdavis.edu
530-752-8363
American Journal of Clinical Nutrition
21-Jun-2001


Page: 1

Related biology news :

1. Genes can influence both alcohol consumption and dependence
2. Parents are top influence on soft-drink consumption among kids
3. Milk consumption and calcium intake associated with lower colorectal cancer risk
4. Moderate alcohol consumption increases plasma levels of a protective hormone
5. Researchers find no link between alcohol consumption during pregnancy and asthma during childhood
6. Soy consumption could help prevent prostate cancer and male pattern baldness
7. Alcohol consumption can damage hearing
8. Link between alcohol consumption and muscle damage in females
9. Moderate alcohol consumption after meals can decrease levels of insulin
10. Risk of Hepatitis E from consumption of deer?
11. Researchers find possible link between pre-natal alcohol consumption and diabetes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/7/2019)... ... November 07, 2019 , ... R3 Stem Cell is now offering its ... of 2019. The code to use during checkout is FIFTYOFF and applies to both ... nation’s leader in regenerative therapies with over 12,000 successful stem cell procedures performed nationwide. ...
(Date:11/5/2019)... ... 05, 2019 , ... Catalent, the leading global provider of ... consumer health products, today announced it will present at the upcoming World Orphan ... – 14, 2019. , On Wednesday, Nov. 13 at 3:20 p.m., Philip Wills, ...
(Date:10/30/2019)... CUMBERLAND FORESIDE, Maine (PRWEB) , ... October 29, ... ... UC4 linearity and calibration verification kits, for SIEMENS ATELLICA® analyzers, Order Numbers 701sa ... GLU, K, MG, NA, PHOS, UA, UTP, and UUN. , Each VALIDATE® kit, ...
Breaking Biology News(10 mins):
(Date:11/19/2019)... ... November 19, 2019 , ... Supercomputing Conference – Cirrascale ... for Autonomous Vehicle , Medical Imaging, and Natural Language Processing (NLP) workflows, ... Graphcore Poplar® software stack as part of its bare-metal cloud service offerings. In ...
(Date:11/12/2019)... ... 12, 2019 , ... Fiberstar, Inc., a global market leader ... a new innovative website. , After extensive research, Fiberstar revamped the ... updated ingredient usage tables by food application and video tutorials. And, this site ...
(Date:11/9/2019)... BOSTON (PRWEB) , ... November ... ... provider of artificial intelligence (AI)-powered technology for use in pathology research, today ... in liver biopsy samples from patients enrolled in the phase 3 selonsertib ...
(Date:11/5/2019)... N.J. (PRWEB) , ... November ... ... global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, ... its next-generation cell line development technology, GPEx® Boost. The technology enhances Catalent’s ...
Breaking Biology Technology:
Cached News: